PRA International Expert Hosts Audio Conference

Clinical Trials: Why is India Irresistible?

RALEIGH, North Carolina, January 18 - PRA International, a leading Clinical Research Organization, announces
that its Director of Clinical Operations for PRA India, Pramod Kabra, M.D.
will host an audio conference to discuss the advantages of conducting
clinical trials in India and the reasons why the region is irresistible for
global clinical development. Dr. Kabra will present the audio conference on
28 January 2010 from 11:30 a.m. to 12:30 p.m. EST. For additional information
and to register, please navigate to www.praintl.com and click on "Events"
under the News and Events heading.

Dr. Kabra's discussion will focus on the major factors that have made
India one of the most attractive regions in the world to conduct clinical
trial research: large patient populations, specialty hospitals and highly
skilled English-speaking medical professionals. Based on his experience in
India, Dr. Kabra will provide attendees with insight into the regional
challenges and opportunities and he will make recommendations for strategies
to overcome the challenges in order to maximize the "India advantage."

Dr. Kabra has more than 12 years of experience in the clinical research
industry, working in academic institutes, pharmaceutical companies and
clinical research organizations. In India, he has monitored more than 100
clinical studies in diverse therapeutic areas. Through his substantial
experience, he has developed a comprehensive understanding of the regulatory
and ethics processes and has built relationships with key investigative sites
in the region.

PRA's presence in India enables its clients to access the compelling
opportunities for swift, meticulous, and cost-effective patient recruitment
in this region. Through its office in Mumbai, PRA has managed more than 40
clinical trials in India in the last three years.

About PRA International

PRA International conducts clinical trials in more than 75 countries
across 6 continents and provides services through all phases of clinical
development. PRA performs studies in all therapeutic areas, with
specialization in oncology, neurosciences, respiratory/allergy,
cardiovascular and infectious diseases. PRA has supported over 2,100 clinical
trials through its 36 global offices.

PRA's therapeutic expertise, global reach and project experience,
combined with extensive local knowledge and our differentiating PERSONAL
ELEMENT enable our project teams to deliver consistent and on time
performance for our clients. This unique PRA philosophy - THE PERSONAL
ELEMENT - recognizes that true client service comes only from trained,
empowered and dedicated employees who are encouraged to use innovation and
their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit
www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global
Headquarters at +1-919-786-8200.

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924